Prevention of Relapse in Behavioral Disorders

Sponsor
Clínica Nuestra Señora de la Paz
Study ID
NCT07052175
Status
Recruiting
Apply to this trial

Conditions

  • Substance-related Disorders

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Standard Multidisciplinary Treatment — BEHAVIORAL
    Comprehensive intervention including structured phases: initial assessment, detoxification, withdrawal management, psychological and psychiatric therapy, rehabilitation, and follow-up care. Delivered by a multidisciplinary team according to established clinical protocols.
  • Digital Monitoring Tool — BEHAVIORAL
    In addition to standard care, participants will use a mobile application that monitors clinical indicators, detects early signs of relapse risk, and provides personalized alerts and intervention prompts. The tool is designed to support both patients and clinicians in decision-making and therapeutic follow-up.

Study Details

This study aims to validate the effectiveness of a digital tool for monitoring and early relapse detection in addiction treatment. It compares outcomes between a traditional multidisciplinary model and the same model enhanced by the technology. The research seeks to demonstrate the tool's added clinical value in improving long-term recovery outcomes.

Key Dates

First listed
Jul 4, 2025
Start date
Apr 1, 2026
Status verified
Dec 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
150 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Active Comparator: Standard Treatment Group
    Participants in this group will receive the standard multidisciplinary treatment for substance use disorders, including clinical evaluation, medical detoxification, psychological and psychiatric therapy, occupational rehabilitation, and social reintegration, without the use of the digital tool
  • Experimental: Digital-Assisted Treatment Group
    Participants in this group will receive the same standard multidisciplinary treatment as Arm 1, complemented by a digital tool designed for real-time monitoring, early relapse detection, and personalized feedback throughout the follow-up phase

Primary Outcome Measure

Biological Verification of Substance Use Relapse via Toxicological Testing: Urinalysis [ Time Frame: Throughout the intervention and follow-up phases (baseline to 12 months) ]

Central Contacts

Related Studies